Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FQVAM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,023
Award facts
- Contract value 100% obligated
- $2,022.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes valued at $2,022.79 on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price terms and is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic and inflammatory conditions, indicating this delivery supports medical supply needs within the federal healthcare system.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen operates as a major pharmaceutical distributor and serves as a critical vendor for federal military and veteran healthcare procurement through this IDC, which enables the company to supply an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies. The DLA Troop Support Medical contract represents AmerisourceBergen's significant role within the Defense Health Agency's pharmaceutical supply chain supporting military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FQVAM?
SPE2DB25FQVAM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FQVAM worth?
The government has obligated $2,023 on SPE2DB25FQVAM.
Is contract SPE2DB25FQVAM an order under another contract?
Yes. SPE2DB25FQVAM is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVAM competed?
The extent of competition for SPE2DB25FQVAM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award